1. Home
  2. NSPR vs LFT Comparison

NSPR vs LFT Comparison

Compare NSPR & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • LFT
  • Stock Information
  • Founded
  • NSPR 2005
  • LFT 2012
  • Country
  • NSPR United States
  • LFT United States
  • Employees
  • NSPR N/A
  • LFT N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • LFT Real Estate Investment Trusts
  • Sector
  • NSPR Health Care
  • LFT Real Estate
  • Exchange
  • NSPR Nasdaq
  • LFT Nasdaq
  • Market Cap
  • NSPR 99.7M
  • LFT 82.2M
  • IPO Year
  • NSPR N/A
  • LFT N/A
  • Fundamental
  • Price
  • NSPR $1.81
  • LFT $1.52
  • Analyst Decision
  • NSPR Strong Buy
  • LFT Hold
  • Analyst Count
  • NSPR 2
  • LFT 1
  • Target Price
  • NSPR $4.50
  • LFT N/A
  • AVG Volume (30 Days)
  • NSPR 119.5K
  • LFT 191.4K
  • Earning Date
  • NSPR 11-04-2025
  • LFT 11-07-2025
  • Dividend Yield
  • NSPR N/A
  • LFT 15.79%
  • EPS Growth
  • NSPR N/A
  • LFT N/A
  • EPS
  • NSPR N/A
  • LFT 0.18
  • Revenue
  • NSPR $7,779,000.00
  • LFT $25,803,999.00
  • Revenue This Year
  • NSPR $7.48
  • LFT $124.75
  • Revenue Next Year
  • NSPR $104.39
  • LFT N/A
  • P/E Ratio
  • NSPR N/A
  • LFT $8.45
  • Revenue Growth
  • NSPR 14.04
  • LFT N/A
  • 52 Week Low
  • NSPR $1.77
  • LFT $1.50
  • 52 Week High
  • NSPR $3.80
  • LFT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 22.72
  • LFT 19.13
  • Support Level
  • NSPR $2.05
  • LFT $1.50
  • Resistance Level
  • NSPR $2.40
  • LFT $1.75
  • Average True Range (ATR)
  • NSPR 0.15
  • LFT 0.06
  • MACD
  • NSPR -0.03
  • LFT -0.00
  • Stochastic Oscillator
  • NSPR 29.05
  • LFT 7.94

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About LFT Lument Finance Trust Inc.

Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.

Share on Social Networks: